FTC challenging patents on 20 brand name drugs : vimarsana.c

Federal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.

Related Keywords

Florida , United States , Washington , Americans , Joe Biden , Lina Khan , Commission On , Drug Administration , Glaxosmithkline , Boehringer Ingelheim Companies , Astrazeneca , Boehringer Ingelheim , Novo Nordisk , Federal Trade Commission , President Joe Biden , Fda , Tc , Federal Regulators , Ozempic , Asthma , Diabetes , Drugs , Health , Medicine , Respiratory Condition , Weight Loss , Snd ,